Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.

about

Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.

Item

http://www.wikidata.org/entity/Q40322550

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Baseline HBV load increases th ...... in patients with tuberculosis.

@en

type

Item

label

Baseline HBV load increases th ...... in patients with tuberculosis.

@en

prefLabel

Baseline HBV load increases th ...... in patients with tuberculosis.

@en

P1476

Baseline HBV load increases th ...... in patients with tuberculosis.

@en

P2093

Chun-Hui Zhu

http://www.w3.org/2001/XMLSchema#string

Dong Xu

http://www.w3.org/2001/XMLSchema#string

Guang Chen

http://www.w3.org/2001/XMLSchema#string

Jian-Xin Song

http://www.w3.org/2001/XMLSchema#string

Jun-Ying Qi

http://www.w3.org/2001/XMLSchema#string

Man-Zhi Zhao

http://www.w3.org/2001/XMLSchema#string

Qin Ning

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis

Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.

Antituberculosis drugs and hepatotoxicity.

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.

Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment.

A prospective study of hepatitis during antituberculous treatment in Taiwanese patients and a review of the literature.

Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.

Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load.

Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.

P2888

s11596-017-1702-3

P304

105-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11596-017-1702-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28224437

http://www.w3.org/2001/XMLSchema#string